Temporal regulation of Lsp1 O-GlcNAcylation and phosphorylation during apoptosis of activated B cells

Nature Communications

Volumn 7, Issue , 2016, Pages

  Wu, Jung Lin ^a,b   Chen, Yu Ju ^c   Wu, Hsin Yi ^c   Tsai, Dong Yan ^a,b   Chiang, Ming Feng ^b   Chen, Yi Ju ^c   Gao, Shijay ^d   Lin, Chun Cheng ^e   Lin, Chun Hung ^d   Khoo, Kay Hooi ^d   Lin, Kuo I ^b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b GENOMICS RESEARCH CENTER   (Taiwan)

^c INSTITUTE OF CHEMISTRY   (Taiwan)

^d INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

^e NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; B LYMPHOCYTE RECEPTOR; CALCIUM; HISTONE DEACETYLASE 1; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN RECEPTOR SUBSTRATE 2; LYMPHOCYTE SPECIFIC PROTEIN 1; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOPROTEIN; PROTEIN; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE; PROTEIN KINASE BLNK; PROTEIN KINASE C BETA1; PROTEIN KINASE LYN; PROTEIN KINASE SYK; PROTEIN TYROSINE PHOSPHATASE SHP 1; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG; BETA N ACETYLHEXOSAMINIDASE; CALCIUM BINDING PROTEIN; ENZYME INHIBITOR; HEXOSAMINIDASE C; LSP1 PROTEIN, MOUSE; N ACETYLGLUCOSAMINE; PROTEIN KINASE C BETA; PYRAN DERIVATIVE; THIAMET G; THIAZOLE DERIVATIVE;

APOPTOSIS; CELLS AND CELL COMPONENTS; CHEMICAL ALTERATION; ENZYME ACTIVITY; MOLECULAR ANALYSIS; RODENT; TEMPORAL VARIATION;

ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; DOWN REGULATION; MOUSE; NONHUMAN; O GLCNACYLATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; SPLENIC B CELL; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; GLYCOSYLATION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PHOSPHORYLATION;

ACETYLGLUCOSAMINE; ANIMALS; APOPTOSIS; B-LYMPHOCYTES; BETA-N-ACETYLHEXOSAMINIDASES; CALCIUM-BINDING PROTEINS; ENZYME INHIBITORS; GLYCOSYLATION; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; PROTEIN KINASE C BETA; PYRANS; SIGNAL TRANSDUCTION; THIAZOLES;

EID: 84984655255     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms12526     Document Type: Article

References (42)

1. Kurosaki, T. Regulation of B-cell signal transduction by adaptor proteins. Nat. Rev. Immunol. 2, 354-363 (2002).
2. Grimaldi, C. M., Hicks, R. & Diamond, B. B cell selection and susceptibility to autoimmunity. J. Immunol. 174, 1775-1781 (2005).
3. Bond, M. R. & Hanover, J. A. O-GlcNAc cycling: a link between metabolism and chronic disease. Annu. Rev. Nutr. 33, 205-229 (2013).
4. McClain, D. A. & Crook, E. D. Hexosamines and insulin resistance. Diabetes 45, 1003-1009 (1996).
5. Liu, F., Iqbal, K., Grundke-Iqbal, I., Hart, G. W. & Gong, C. X. O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimers disease. Proc. Natl Acad. Sci. USA 101, 10804-10809 (2004).
6. Cheng, X. & Hart, G. W. Alternative O-glycosylation/O-phosphorylation of serine-16 in murine estrogen receptor beta: post-translational regulation of turnover and transactivation activity. J. Biol. Chem. 276, 10570-10575 (2001).
7. Yang, W. H., et al. Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability. Nat. Cell Biol. 8, 1074-1083 (2006).
8. Doll, S. & Burlingame, A. L. Mass spectrometry-based detection and assignment of protein posttranslational modifications. ACS Chem. Biol. 10, 63-71 (2015).
9. Kearse, K. P. & Hart, G. W. Lymphocyte activation induces rapid changes in nuclear and cytoplasmic glycoproteins. Proc. Natl Acad. Sci. USA 88, 1701-1705 (1991).
10. Golks, A. & Guerini, D. The O-linked N-acetylglucosamine modification in cellular signalling and the immune system. Protein modifications: beyond the usual suspects review series. EMBO Rep. 9, 748-753 (2008).
11. Golks, A., Tran, T. T., Goetschy, J. F. & Guerini, D. Requirement for O-linked N-acetylglucosaminyltransferase in lymphocytes activation. EMBO J. 26, 4368-4379 (2007).
12. Yuzwa, S. A., et al. A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo. Nat. Chem. Biol. 4, 483-490 (2008).
13. Macauley, M. S., Whitworth, G. E., Debowski, A. W., Chin, D. & Vocadlo, D. J. O-GlcNAcase uses substrate-assisted catalysis: kinetic analysis and development of highly selective mechanism-inspired inhibitors. J. Biol. Chem. 280, 25313-25322 (2005).
14. Xu, W., Doshi, A., Lei, M., Eck, M. J. & Harrison, S. C. Crystal structures of c-Src reveal features of its autoinhibitory mechanism. Mol. Cell 3, 629-638 (1999).
15. Tsai, C. F., et al. Immobilized metal affinity chromatography revisited: pH/acid control toward high selectivity in phosphoproteomics. J. Proteome Res. 7, 4058-4069 (2008).
16. Tsou, C. C., et al. IDEAL-Q, an automated tool for label-free quantitation analysis using an efficient peptide alignment approach and spectral data validation. Mol. Cell. Proteomics 9, 131-144 (2010).
17. Wang, Y. T., et al. An informatics-assisted label-free quantitation strategy that depicts phosphoproteomic profiles in lung cancer cell invasion. J. Proteome Res. 9, 5582-5597 (2010).
18. Tsai, C. F., et al. Large-scale determination of absolute phosphorylation stoichiometries in human cells by motif-targeting quantitative proteomics. Nat. Commun. 6, 6622 (2015).
19. Jongstra-Bilen, J., Wielowieyski, A., Misener, V. & Jongstra, J. LSP1 regulates anti-IgM induced apoptosis in WEHI-231 cells and normal immature B-cells. Mol. Immunol. 36, 349-359 (1999).
20. Monsigny, M., et al. Properties of succinylated wheat-germ agglutinin. Eur. J. Biochem. 98, 39-45 (1979).
21. Mizuno, T., Zhong, X. & Rothstein, T. L. Fas-induced apoptosis in B cells. Apoptosis 8, 451-460 (2003).
22. Klein, D. P., Galea, S. & Jongstra, J. The lymphocyte-specific protein LSP1 is associated with the cytoskeleton and co-caps with membrane IgM. J. Immunol. 145, 2967-2973 (1990).
23. Jongstra-Bilen, J., Janmey, P. A., Hartwig, J. H., Galea, S. & Jongstra, J. The lymphocyte-specific protein LSP1 binds to F-actin and to the cytoskeleton through its COOH-terminal basic domain. J. Cell Biol. 118, 1443-1453 (1992).
24. Melamed, I. & Gelfand, E. W. Microfilament assembly is involved in B-cell apoptosis. Cell. Immunol. 194, 136-142 (1999).
25. Faulstich, H., Zobeley, S., Bentrup, U. & Jockusch, B. M. Biotinylphallotoxins: preparation and use as actin probes. J. Histochem. Cytochem. 37, 1035-1045 (1989).
26. Kamesaki, H., Zwiebel, J. A., Reed, J. C. & Cossman, J. Role of bcl-2 and IL-5 in the regulation of anti-IgM-induced growth arrest and apoptosis in immature B cell lines. A cooperative regulation model for B cell clonal deletion. J. Immunol. 152, 3294-3305 (1994).
27. Merino, R., et al. Modulation of anti-IgM-induced B cell apoptosis by Bcl-xL and CD40 in WEHI-231 cells. Dissociation from cell cycle arrest and dependence on the avidity of the antibody-IgM receptor interaction. J. Immunol. 155, 3830-3838 (1995).
28. Harrison, R. E., Sikorski, B. A. & Jongstra, J. Leukocyte-specific protein 1 targets the ERK/MAP kinase scaffold protein KSR and MEK1 and ERK2 to the actin cytoskeleton. J. Cell Sci. 117, 2151-2157 (2004).
29. Carballo, E., Colomer, D., Vives-Corrons, J. L., Blackshear, P. J. & Gil, J. Characterization and purification of a protein kinase C substrate in human B cells. Identification as lymphocyte-specific protein 1 (LSP1). J. Immunol. 156, 1709-1713 (1996).
30. Wu, Y., et al. MAPKAPK2-mediated LSP1 phosphorylation and FMLP-induced neutrophil polarization. Biochem. Biophys. Res. Commun. 358, 170-175 (2007).
31. Doughty, C. A., et al. Antigen receptor-mediated changes in glucose metabolism in B lymphocytes: role of phosphatidylinositol 3-kinase signaling in the glycolytic control of growth. Blood 107, 4458-4465 (2006).
32. Macauley, M. S. & Vocadlo, D. J. Increasing O-GlcNAc levels: an overview of small-molecule inhibitors of O-GlcNAcase. Biochim. Biophys. Acta 1800, 107-121 (2010).
33. Comer, F. I. & Hart, G. W. Reciprocity between O-GlcNAc and O-phosphate on the carboxyl terminal domain of RNA polymerase II. Biochemistry 40, 7845-7852 (2001).
34. Guo, B., Su, T. T. & Rawlings, D. J. Protein kinase C family functions in B-cell activation. Curr. Opin. Immunol. 16, 367-373 (2004).
35. Marafioti, T., et al. Leucocyte-specific protein (LSP1) in malignant lymphoma and Hodgkins disease. Br. J. Haematol. 120, 671-678 (2003).
36. Miyoshi, E. K., et al. Aberrant expression and localization of the cytoskeletonbinding pp52 (LSP1) protein in hairy cell leukemia. Leuk. Res. 25, 57-67 (2001).
37. Chang, C. C., Wright, A. & Punnonen, J. Monocyte-derived CD1a and CD1a- dendritic cell subsets differ in their cytokine production profiles, susceptibilities to transfection, and capacities to direct Th cell differentiation. J. Immunol. 165, 3584-3591 (2000).
38. Lin, F. R., Kuo, H. K., Ying, H. Y., Yang, F. H. & Lin, K. I. Induction of apoptosis in plasma cells by B lymphocyte-induced maturation protein-1 knockdown. Cancer Res. 67, 11914-11923 (2007).
39. Su, S. T., et al. Involvement of histone demethylase LSD1 in Blimp-1-mediated gene repression during plasma cell differentiation. Mol. Cell Biol. 29, 1421-1431 (2009).
40. Brizzard, B. L., Chubet, R. G. & Vizard, D. L. Immunoaffinity purification of FLAG epitope-tagged bacterial alkaline phosphatase using a novel monoclonal antibody and peptide elution. BioTechniques 16, 730-735 (1994).
41. Olsen, J. V., et al. Parts per million mass accuracy on an Orbitrap mass spectrometer via lock mass injection into a C-trap. Mol. Cell. Proteomics 4, 2010-2021 (2005).
42. Vizcaino, J. A., et al. The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Res. 41, D1063-D1069 (2013).